Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Decreased Serum Level and Increased Urinary Excretion of Vascular Endothelial Growth Factor-C in Chronic Kidney Disease Patients
저자 Sun Hee Kim, Yu Jin Jung, Kyung Pyo Kang, Sik Lee, Sung Kwang Park, Won Kim
출판정보 2013; 2013(1):
키워드 만성신질환, 고혈압, 혈관내피세포성장인자-C/VEGF-C, Hypertension, Chronic kidney disease
초록 Background: Interstitial tonicity increases vascular endothelial growth factor-C (VEGF-C), a lymphangiogenic factor, in salt-induced hypertension. Therefore, it can be assumed that changes of serum VEGF-C level may be associated with increasing blood pressure. However, there is no report about the changes of serum VEGF-C levels in patients with chronic kidney disease (CKD). The aims of this study were to investigate the changes of serum and urine VEGFC levels in CKD stage 3-4 patients, and to evaluate the relationship between blood pressure and serum VEGF-C levels in the CKD stage 5 patients with hemodialysis. Methods: Glomerular filtration rate (GFR) was assessed by the MDRD equation. Blood pressure and VEGF-C levels (serum and urine) were measured by enzyme linked immunosorbant assay (ELISA) in 9 patients with stage 3-4 CKD, 41 hemodialysis patients and in 8 healthy individuals. The study also evaluated the relationship between serum VEGF-C levels and stage of blood pressure. Results: The mean systolic and diastolic blood pressures of stage 3-4 CKD and hemodialysis patients were significantly higher than that of the healthy controls. The mean serum level of VEGF-C in stage 3-4 CKD and stage 5 hemodialysis patients significantly decreased when compared to healthy subjects (202.3±204.0 pg/mL in stage 3-4 CKD, 425.4± 943.7 in hemodialysis patient, 4,913±5,786 in control; p value <0.05). The urine VEGF- C (pg) per urine creatinine (mg) were significantly increased in stage 3-4 CKD patients compared with healthy controls (35.8±9.8 ng of urine VEGF-C per mg of urine creatinine to stage 3-4 CKD patients, 177.0±113.5 to healthy controls; p value<0.01). The fractional excretion of VEGF-C was also increased in patients with stage 3-4 CKD compared with healthy controls (6.43±6.25% to stage 3-4 CKD patients and 0.01±0.02 to healthy controls; p value<0.01). For 41 hemodialysis patients, the concentrations of serum VEGF-C in patients with stage 1 hypertension (98.60 +/- 26.99 pg/ml) or stage 2 hypertension tended to be higher than those in healthy controls (80.44 +/- 24.57), but the differences did not reach statistical significance. The serum levels of VEGF-C in patients with CKD stage 5 were not correlated with the number of anti-hypertensive drugs used. Conclusion: We suggest that circulating levels of VEGF-C were decreased in patient with CKD. The decrease of VEGF-C in stage 3-4 CKD patients coincided with an increase in the uri
원문(PDF) PDF 원문보기
위로가기